With its wide-ranging assets, LGI plans to accelerate the global adaptation of clinical-grade wireless biosensors by working with healthcare device OEMs and service providers, thereby improving healthcare delivery to currently underserved populations.

“I am delighted to see this merger come to fruition,” comments Magar. “Combining the assets of both parties brings the scale and resources required for LifeSignals to accelerate its vision of promoting multiparameter clinical-grade wireless biosensor patches, and replace the billions of “wired” biosensors (e.g. ECG electrodes) that currently dominate the clinical monitoring arena. Overall, the combination of our wireless proprietary smart biosensor technology with the flexible cloud-based analytics, will enable patients and healthcare providers to receive potentially life-saving, real-time analysis of health data at a level that did not previously exist.”

Fast-growing Renew Health, co-founded by entrepreneur and visionary Ravinder Sajwan, foresees great potential in this merger. “The Renew Group has long recognised the potential of LifeSignals to lead wireless biosensor adaptation on a global scale due to the unmatched power of its processor technology. Having made major investments in the connected health technologies that are complementary to LifeSignals biosensors, we see it as a natural progression to merge the connected health assets of Renew with LifeSignals Inc., to create LifeSignals Group Inc. Post-merger, Renew will concentrate its resources on the manufacture and global distribution of our unique commercial product portfolio” says CEO Ravinder Sajwan who will serve on the Board of Directors of LifeSignals Group Inc.

For more information on LifeSignals visit: www.lifesignals.com

 

Recommended Posts